» Articles » PMID: 34646081

Novel Approaches to the Management of Recurrent Pregnancy Loss: The OPTIMUM (OPtimization of Thyroid Function, Thrombophilia, Immunity, and Uterine Milieu) Treatment Strategy

Overview
Journal Reprod Med Biol
Specialty Biology
Date 2021 Oct 14
PMID 34646081
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: Does the OPtimization of Thyroid function, Thrombophilia, Immunity, and Uterine Milieu (OPTIMUM) treatment strategy, developed for treating repeated implantation failure (RIF), contribute to improving pregnancy outcomes in patients with a history of recurrent pregnancy loss (RPL)?

Methods: Between 2018 and 2019, women with RPL after two or more clinical pregnancy losses underwent RPL testing. We treated chronic endometritis with antibiotics, high Th1/Th2 cell ratios with vitamin D and/or tacrolimus, overt/subclinical hypothyroidism with levothyroxine, and thrombophilia with low-dose aspirin. Of 168 consecutive women aged ≤43 years, 115 underwent RPL testing. We compared 100 pregnancies (90 women) and 46 pregnancies (41 women) with and without the OPTIMUM treatment strategy, respectively.

Results: RPL testing identified intrauterine abnormalities in 66 (57.4%), elevated Th1/Th2 cell ratios in 50 (43.5%), thyroid dysfunction in 33 (28.7%), and thrombophilia in 33 (28.7%). The live birth rate in the OPTIMUM group was significantly higher than that in the control group among women aged <40 years (78.1% and 42.3%, respectively;  = 0.002), but no significant difference was observed in women aged ≥40 years (55.6% and 30.0%, respectively;  = 0.09).

Conclusions: The OPTIMUM treatment strategy improved pregnancy outcomes in patients with not only RIF but also RPL.

Citing Articles

Causes of embryo implantation failure: A systematic review and metaanalysis of procedures to increase embryo implantation potential.

Bulletti F, Sciorio R, Conforti A, De Luca R, Bulletti C, Palagiano A Front Endocrinol (Lausanne). 2025; 15:1429193.

PMID: 40028443 PMC: 11867936. DOI: 10.3389/fendo.2024.1429193.


Exploring the Immunological Aspects and Treatments of Recurrent Pregnancy Loss and Recurrent Implantation Failure.

Garmendia J, De Sanctis C, Hajduch M, De Sanctis J Int J Mol Sci. 2025; 26(3).

PMID: 39941063 PMC: 11818386. DOI: 10.3390/ijms26031295.


Management strategies following implantation failure of euploid embryos.

Kuroda K Reprod Med Biol. 2024; 23(1):e12576.

PMID: 38590944 PMC: 11000815. DOI: 10.1002/rmb2.12576.


A review of the optimization of thyroid function, thrombophilia, immunity and uterine milieu treatment strategy for recurrent implantation failure and recurrent pregnancy loss.

Kuroda K Reprod Med Biol. 2024; 23(1):e12561.

PMID: 38249354 PMC: 10797160. DOI: 10.1002/rmb2.12561.


Therapeutic efficacy of the optimization of thyroid function, thrombophilia, immunity and uterine milieu (OPTIMUM) treatment strategy on pregnancy outcomes after single euploid blastocyst transfer in advanced age women with recurrent reproductive....

Kuroda K, Horikawa T, Moriyama A, Ojiro Y, Takamizawa S, Watanabe H Reprod Med Biol. 2023; 22(1):e12554.

PMID: 38144238 PMC: 10739138. DOI: 10.1002/rmb2.12554.


References
1.
Kuroda K, Venkatakrishnan R, James S, Sucurovic S, Mulac-Jericevic B, Lucas E . Elevated periimplantation uterine natural killer cell density in human endometrium is associated with impaired corticosteroid signaling in decidualizing stromal cells. J Clin Endocrinol Metab. 2013; 98(11):4429-37. PMC: 4207949. DOI: 10.1210/jc.2013-1977. View

2.
Segawa T, Kuroda T, Kato K, Kuroda M, Omi K, Miyauchi O . Cytogenetic analysis of the retained products of conception after missed abortion following blastocyst transfer: a retrospective, large-scale, single-centre study. Reprod Biomed Online. 2016; 34(2):203-210. DOI: 10.1016/j.rbmo.2016.11.005. View

3.
Boots C, Bernardi L, Stephenson M . Frequency of euploid miscarriage is increased in obese women with recurrent early pregnancy loss. Fertil Steril. 2014; 102(2):455-9. DOI: 10.1016/j.fertnstert.2014.05.005. View

4.
Salker M, Nautiyal J, Steel J, Webster Z, Sucurovic S, Nicou M . Disordered IL-33/ST2 activation in decidualizing stromal cells prolongs uterine receptivity in women with recurrent pregnancy loss. PLoS One. 2013; 7(12):e52252. PMC: 3531406. DOI: 10.1371/journal.pone.0052252. View

5.
Nakagawa K, Kuroda K, Sugiyama R, Yamaguchi K . After 12 consecutive miscarriages, a patient received immunosuppressive treatment and delivered an intact baby. Reprod Med Biol. 2017; 16(3):297-301. PMC: 5715883. DOI: 10.1002/rmb2.12040. View